Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.52 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.43 |
| ▸ | FAAH | O00519 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.42 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL994607 | 0.92 | TSHR (0.73) | TSHRGABRA1GABRB2GABRG2GABRB3 | |
| Hydrogen Peroxide SCHEMBL3675725 | 0.87 | TSHR (0.74) | TSHRGABRA1GABRB2LMNAL3MBTL1 | |
| SCHEMBL9621456 | 0.85 | TSHR (0.64) | TSHRGABRA1GABRB2LMNAL3MBTL1 | |
| SCHEMBL27826854 | 0.83 | TSHR (0.61) | TSHRGABRA1GABRB2LMNAL3MBTL1 | |
| SCHEMBL10246803 | 0.81 | TSHR (0.59) | TSHRGABRA1GABRB2L3MBTL1KDM4E | |
| SCHEMBL14341530 | 0.81 | TSHR (0.65) | TSHRGABRA1GABRB2GABRG2GABRB3 | |
| SCHEMBL66162 | 0.81 | GABRA1 (0.63) | TSHRGABRA1GABRB2GABRG2GABRB3 | |
| SCHEMBL29429205 | 0.81 | GABRA1 (0.63) | TSHRGABRA1GABRB2GABRG2GABRB3 | |
| SCHEMBL944816 | 0.80 | TSHR (0.64) | TSHRGABRA1GABRB2LMNAL3MBTL1 | |
| SCHEMBL8731749 | 0.80 | TSHR (0.64) | TSHRGABRA1GABRB2LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2867191-B1 | PROCESS FOR PRODUCING CUMENE | BADGER LICENSING LLC (US) | 2019-09-11 | — | — | EP | claimed |
| CN-109438157-B | Process for producing cumene | 巴杰许可有限责任公司 | 2024-05-14 | — | — | CN | disclosed |
| EP-2867191-B1 | PROCESS FOR PRODUCING CUMENE | BADGER LICENSING LLC (US) | 2019-09-11 | — | — | EP | disclosed |
| CN-109438157-A | The method for producing cumene | 巴杰许可有限责任公司 | 2019-03-08 | — | — | CN | disclosed |
| US-9850187-B2 | Process for producing cumene | BADGER LICENSING LLC (US) | 2017-12-26 | — | — | US | disclosed |
| US-20170239365-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | MEDIMMUNE LIMITED (GB) | 2017-08-24 | — | — | US | disclosed |
| US-20150183695-A1 | PROCESS FOR PRODUCING CUMENE | BADGER LICENSING LLC (US) | 2015-07-02 | — | — | US | disclosed |
| EP-2867191-A1 | PROCESS FOR PRODUCING CUMENE | Badger Licensing, LLC (US) | 2015-05-06 | — | — | EP | disclosed |
| CN-104411662-A | Process for producing cumene | BADGER LICENSING LLC | 2015-03-11 | — | — | CN | disclosed |
| WO-2014003732-A1 | PROCESS FOR PRODUCING CUMENE | BADGER LICENSING LLC (US) | 2014-01-03 | — | — | WO | disclosed |
| EP-0985649-B1 | Method for producing an aromatic compound having an alkyl group with at least three carbon atoms | TORAY INDUSTRIES (JP) | 2004-11-24 | — | — | EP | disclosed |
| US-6462248-B1 | THROUGH CONVERSION, ISOMERIZATION AND/OR ADSORPTIVE SEPARATION OF AROMATIC COMPOUNDS | TORAY INDUSTRIES, INC. (JP) | 2002-10-08 | — | — | US | disclosed |
| EP-0985649-A2 | Method for producing an aromatic compound having an alkyl group with at least three carbon atoms | TORAY INDUSTRIES, INC. (JP) | 2000-03-15 | — | — | EP | disclosed |
| US-4929747-A | POLYMERIZATION CATALYSTS | NIPPON OIL & FATS COMPANY, LTD. (JP) | 1990-05-29 | — | — | US | disclosed |
| US-4059637-A | COUNTERCURRENT MULTISTAGE SOLVENT EXTRACTION | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1977-11-22 | — | — | US | disclosed |
| US-4003846-A | ACROLEIN POLYMER, POLYALKYLENIMINE | CIBA-GEIGY CORPORATION (US) | 1977-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170239365-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | CD79B, BOD1L1, GABRA1 | TSHR 1750/4885GABRA1 3/4885GABRB2 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.